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Abstract
Background: We evaluated whether diet quality is a predictor of weight loss and reduced diabetes risk,
independent of caloric intake in the Diabetes Prevention Program (DPP) cohort, a randomized clinical trial of adults
at risk for diabetes.
Methods: This secondary analysis included 2914 participants with available data (964 intensive lifestyle (ILS), 977
metformin, 973 placebo). Dietary intake was assessed using a 117-item food frequency questionnaire. Diet quality
was quantified using the Alternative Healthy Eating Index 2010 (AHEI). AHEI ranges from 0 to 110, with higher
scores corresponding to higher quality diets. ILS participants had greater improvement (p < 0.001) in AHEI over 1-
year (4.2 ± 9.0) compared to metformin (1.2 ± 8.5) and placebo (1.4 ± 8.4). We examined the association between
AHEI change and weight change from baseline to 1-year using linear regression, and that between 1-year AHEI
change and incident diabetes, using hazard models over an average 3 years follow-up. Models were evaluated
within treatment group and adjusted for relevant characteristics including caloric intake, physical activity, BMI and
AHEI. Models testing incident diabetes were further adjusted for baseline fasting and 2 h glucose.
Results: An increase in AHEI score was associated with weight loss in ILS [β per 10-point increase (SE) -1.2 kg (0.3,
p < 0.001)], metformin [− 0. 90 kg (0.2, p < 0.001)] and placebo [− 0.55 kg (0.2, p = 0.01)]. However, AHEI change was
not associated with incident diabetes in any group before or after adjustment for weight change.
Conclusions: Controlling for weight, diet quality was not associated with diabetes incidence but helps achieve
weight loss, an important factor in diabetes prevention.
Keywords: AHEI, Body weight, DPP, Prediabetes, Type 2 diabetes, Lifestyle intervention, Obesity, Diabetes
prevention, Dietary pattern, Race
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Background
The role of diet quality in the development of type 2 dia-
betes is not well understood. The relationship remains
challenging to consider due to the paucity of longitudinal
data on diet quality and diabetes, and the confounding ef-
fect of weight loss. Although diabetes incidence decreases
with weight loss, as supported by the Diabetes Prevention
Program (DPP) [1], recent work suggests that weight loss
alone is not sufficient to fully explain the association be-
tween dietary intake and diabetes [2]. There may be an in-
dependent effect of diet quality on diabetes risk.
A preponderance of the work on this question has
adopted a reductionist approach, investigating the im-
pact of a single food group on diabetes incidence whilst,
in most cases, adjusting for total energy intake, physical
activity, and body mass index (BMI). Significant reduc-
tions in diabetes incidence have been reported with in-
creasing intake of whole grains, green leafy vegetables,
and yogurt in meta-analyses of prospective cohort stud-
ies [3–7]. Sugar-sweetened beverages and red meat, on
the other hand, are associated with a significant increase
in diabetes risk in similar meta-analyses of prospective
cohort studies [8, 9]. More than single foods or bever-
ages, overall patterns of healthy and unhealthy dietary
intake may better predict population health outcomes.
Surprisingly few studies have evaluated the effect of
dietary patterns or measures of overall diet quality on
diabetes risk [10]. Cespedes et al. (2016) and Qiao et al.
(2016) showed higher diet quality scores reduced dia-
betes incidence in post-menopausal women participating
in the Women’s Health Initiative [11, 12]. Recent ana-
lyses of the Harvard cohort studies (Nurses’ Health
Study [NHS], NHS II, and the Health Professionals
Follow-up Study) found that a ≥ 10% increase in the
AHEI reduced diabetes incidence by 16% [2].
Most of these studies were in largely homogeneous
populations. de Oliveira Otto et al. and Jacobs et al. ob-
served the impact of diet quality differences on diabetes
risk for more diverse populations, but only for scores at
baseline, not longitudinal changes [13, 14]. Given that
dietary patterns have been shown to vary by race/ethni-
city [15], it remains to be seen whether or not changes
in overall diet quality have an independent effect on dia-
betes risk in more diverse populations.
The lack of studies relating diet quality to diabetes
are due, in part, to measurement issues: there is no
single agreed-upon measure of what “optimal” diet
quality is. In this paper, we use the Alternative
Healthy Eating Index (AHEI) as a proxy for overall
diet quality. The AHEI is a composite score of 11
food groups and nutrients including fruits, vegetables,
whole grains, sugar-sweetened beverages, nuts and le-
gumes, red/processed meats, sodium, fats (trans, poly-
unsaturated, and long chain fats), and alcohol. We
chose to focus on AHEI given that it has the widest
score range of any of these scores (and thus is less
prone to exposure misclassification), was found to be
the most predictive of weight change and chronic dis-
ease outcomes including type 2 diabetes in a previous
study [16], and to facilitate comparisons to previous
studies [11, 12, 17]. The AHEI is highly correlated
with other measures of diet quality, such as the Medi-
terranean diet and the Dietary Approaches to Stop
Hypertension (DASH) diet, likely because these scores
are generally derived from similar sets of food groups
and nutrients.
The objectives of this study were: (1) to estimate the
association between changes in AHEI and weight loss,
over the first year of intervention and diabetes incidence
in the DPP over 3.2 years of follow up, and (2) to deter-
mine if the associations differ across race/ethnicity sub-
populations. We hypothesized that improved diet quality
would be associated with weight loss and decreased dia-
betes incidence in all race/ethnic subgroups.
Methods
Study population
Our sample consists of participants from the DPP.
The DPP was a multicenter randomized controlled
trial, which enrolled participants at a high risk of de-
veloping type 2 diabetes between 1996 and 1999 [18].
A total of 3234 participants were randomized to one
of three treatment groups: intensive lifestyle interven-
tion (ILS, n = 1079), 850 mg metformin twice daily
(n = 1073), or placebo (n = 1082). The lifestyle inter-
vention used an individually-administered 16-session
core curriculum over the first 24 weeks with follow
up post-core sessions at least every other month for
the remainder of the DPP trial. The intervention
followed a standard protocol with the primary inter-
vention goals of achieving and maintaining a weight
loss of ≥7% initial body weight and a moderate inten-
sity activity level of ≥150 min per week [19]. Session
materials and strategies to reduce fat and calorie in-
take were tailored to the needs of an ethnically di-
verse population. Nutrition and corresponding
behavior modification session topics addressed dietary
fat and calorie self-monitoring, managing cues that
shape eating habits, energy balance, and healthy eat-
ing out [19]. Four standard calorie (fat-gram) levels
were assigned according to baseline weight and de-
signed to produce a 1–2 lb. weight loss per week,
with 25% or less of calories from fat. Study protocols
were approved by the institutional review boards at
all sites and written informed consent was obtained
from all participants. This secondary analysis adheres
to the STROBE Statement. DPP is registered in Clini-
calTrials.gov (NCT00004992).
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Diet quality assessment
Dietary intake was assessed by in-person interview at
baseline and year 1 using a 117-item food frequency
questionnaire (FFQ) from the Insulin Resistance Athero-
sclerosis Study (IRAS) FFQ [20], adapted to include eth-
nic and regional foods expected to represent DPP
participants. The IRAS FFQ itself was developed for a
culturally diverse US population and was validated
against eight 24-h dietary recalls completed over the
same 1-year period as the FFQ [21]. For the DPP FFQ,
the main body of the questionnaire contained 117 line
items (compared to 114 line items on the IRAS FFQ),
plus an open-ended query for foods not included within
the line items. Foods added to enhance sensitivity to re-
gional and ethnic foods were identified through queries
to each of the clinical centers.
The nutrient content of foods was determined using
the DietSys Nutrient Analysis Program and Nutrition
Data System (version 2.6/8A/23, Nutrition Coordinating
Center, University of Minnesota, Minneapolis, MN,
USA) by the DPP Nutrition Coding Center at the Uni-
versity of South Carolina. Individual nutrient intake was
estimated by using the frequency and portion size of in-
take for each food item. Food groups were assessed
using as close to the AHEI assessed groups as was avail-
able in the dataset. While the primary analysis for this
study includes the data from the baseline and year 1
visit.
We quantified diet quality using AHEI 2010 [22] with
one modification to accommodate the DPP dietary data
(Supplemental Table 1). Briefly, because DPP did not
contain whole grain grams per day, we substituted daily
servings of high-fiber grains and breads for daily grams
of whole grains. We assumed 5 servings per day for
women and 6 for men. These substitutions occurred
prior to statistical analyses. AHEI ranges from 0 to 110,
with higher scores corresponding to higher quality diets.
Outcome and covariate assessment
Oral glucose tolerance tests (OGTTs) were completed at
annual visits and fasting glucose was obtained at mid-
year visits following standardized procedures during
DPP. Diabetes incidence was defined as a fasting plasma
blood glucose ≥126 mg/dl (7.0 mmol/l) or 2-h post-load
plasma glucose ≥200 mg/dl (11.1 mmol/1), confirmed by
a repeat test within 6 weeks, according to the 1997
American Diabetes Association criteria [18, 23].
Anthropometric measurements were performed with
participants wearing light clothing and without shoes.
Body weight was measured in duplicate on a calibrated
balance beam scale, zeroed before each measurement.
Standing height was determined in duplicate with a cali-
brated standard stadiometer, with the heels shoulder
width apart, in a fully vertical position. Height and
weight measurements were used to calculate BMI (kg/
m2). All staff performing measurements and question-
naires were centrally trained and certified to do so.
Self-reported physical activity was assessed using
the Modifiable Activity Questionnaire and expressed
as the average metabolic equivalent (MET-hours) per
week for the previous year [24] . At the time of DPP
randomization, a screening questionnaire was used to
obtain age, sex, race/ethnicity, educational attainment,
family history of diabetes, history of smoking, and
alcohol intake [18].
Statistical analyses
Changes in AHEI, dietary intake and weight were calcu-
lated as year 1 minus the baseline value so that increases
are reported as positive numbers. Changes in subscores
were compared from baseline to year 1 both visually, by
radar plot, and statistically, via paired t-tests. Descriptive
statistics are presented as percentages, mean ± SD, or
median [Q1, Q3]] for nonnormally distributed data.
Comparisons between groups were computed using
ANOVA for continuous variables and χ2 tests for cat-
egorical variables. Except where noted, P values< 0.05
were considered nominally statistically significant, with
no adjustments made for multiple tests. We examined
the association between AHEI score change and weight
change from baseline to year 1 using linear regression.
We ran three sets of models: (1) a model for all partici-
pants; and (2) models stratified by treatment arm (ILS,
metformin, and placebo) and (3) stratified by race/ethni-
city group. Three sets of linear regression models were
run: Model 1 adjusted for potential confounders includ-
ing baseline values of AHEI, age, sex, BMI, MET
hours per week, total daily energy intake as well as
change from baseline to year one of MET hours per
week and total daily energy intake; Model 2 used Model
1 covariates as well as baseline values of education,
smoking status, family history of diabetes, alcohol use,
and change from baseline to year one of MET hours and
total energy intake; Model 3 also adjusted for baseline
values of dietary fiber, carbohydrate, total fat and satu-
rated fat at baseline and change to year 1 of each.
Models without treatment arm stratification (i.e. models
with all participants or those with race/ethnicity stratifi-
cation) are adjusted for treatment group, and models
without race/ethnicity stratification (i.e. models with all
participants or those with treatment arm stratification)
were adjusted for race/ethnicity.
We used Cox proportional hazard models to estimate
the association of changes in AHEI score with incident
diabetes over 3.2 years of follow-up in DPP (hazard ra-
tios [HR] and 95% confidence intervals [CI]). We ana-
lyzed all participants combined, adjusted for treatment
group, and separately stratified by treatment arm to
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estimate these associations within the placebo, lifestyle,
and metformin groups. We fit models adjusting for base-
line values of AHEI, age, sex, race/ethnicity, education,
total energy intake, physical activity (MET hours), BMI,
fasting and 2 h glucose, family history of diabetes, smok-
ing, and alcohol intake as well change from baseline to
year one of physical activity and total energy intake.
After assessing the interaction between race/ethnicity
and AHEI change, we stratified the analysis by race/eth-
nicity. We further adjusted for baseline weight and
weight change from baseline to year 1 to estimate the
direct and indirect effects, via weight change, of AHEI in
these models.
Additionally, we followed the approach of Hamman
et al. to develop four subgroups based on whether the
participant met a weight change target (reduced weight
by 5% or more from baseline) and if AHEI increased by
10% from baseline at year 1, plotting the hazard ratios
for incident diabetes over 3.2 years of follow-up in DPP
for each subgroup [1]. A 5% weight loss threshold was
chosen because it is a commonly used threshold in pre-
vious studies, including DPP [25]. A 10% increase in
AHEI score is equal to 4.4 increase on average for our
population. The increase can be nearly achieved, for
example, by eliminating sugar-sweetened beverages or
by increasing the servings of fruits and vegetables.
To assess whether AHEI score over time predicts
long-term weight through DPP (approximately 3.2 years
post-randomization), we used mixed linear models for
all participants as well as stratified by treatment group
and race/ethnicity group. SAS version 9.4 was used for
all analyses (SAS Institute, Cary, NC).
Results
Our analysis included 2914 participants (90.1% of those
randomized) with complete baseline and 1-year data
(964 ILS, 977 metformin, and 973 placebo). Participants
included in the analyses were, on average, middle-aged
(mean ± SD, age 50.8 ± 10.6 years) and female (67.5%).
Forty-five percent of the sample was minority race/eth-
nicity; 19% were African American, 16% Hispanic, 5%
American Indian, and 4% Asian.
Mean baseline AHEI and 1-year changes to the
AHEI scores by treatment group are presented in
Table 1. Baseline AHEI for the entire sample was
44.2 ± 10.4. Although we found no differences in base-
line AHEI across treatment groups, ILS participants
had greater improvement (p < 0.001) in AHEI over 1
year (4.2 ± 9.0 points) compared to metformin (1.2 ±
8.5) and placebo (1.4 ± 8.4) participants. In relative
terms, participants saw an increase in AHEI score of
approximately 9.5% relative to baseline over 1 the
first year of intervention among ILS participants com-
pared to 2.7% among metformin and 3.2% among
placebo participants. Increases in AHEI over 1 year
were largely driven by participants consuming less so-
dium, fewer trans fats, and fewer sugar-sweetened
beverages (Fig. 1). Paired t-tests (results available
upon request) comparing the baseline and year 1
score component values (points contributed) within
study group revealed statistically significant changes
for all components for the Lifestyle Group (p < 0.05).
All components except vegetables and alcohol had
statistically significant changes within the Metformin
group (p < 0.05). In the Placebo group, only vegeta-
bles, sweet beverages, trans fat and sodium had sig-
nificant changes from baseline to year 1. Mean
baseline AHEI and 1-year changes to the AHEI scores
by racial/ethnic group are presented in Supplemental
Table 2. Asian participants had the highest mean
baseline AHEI (47.6 ± 10.1), more than 10 points
higher than the lowest racial/ethnic group (American
Indian, 37.2 ± 8.8).
Change in AHEI from baseline to 1 year was signifi-
cantly associated with weight loss at year 1 [β per 10-
point increase (SE, p-value) -0. 89 kg (0.13, p < 0.001),
Table 2]. Results were consistent across the ILS [−
1.23 kg (0.28, p < 0.001)], metformin [− 0.90 kg (0.19,
p < 0.001)], and placebo [− 0.55 kg (0.20, p = 0.01)]
groups (p-interaction = 0.083). The interaction term
for race/ethnicity and AHEI change was significant
(p = 0.020), thus the model was stratified by race/eth-
nicity as well. AHEI change was associated with
weight loss, especially in Caucasian [− 1.13 kg (0.19,
p < 0.001)], Hispanic [− 0.85 kg (0.29, p = 0.003)] and
American Indian (− 0.90, p = 0.156) participants. The
effect sizes for African American (− 0.36, p = 0.216),
and Asian (0.49, p = 0.286) participants were much
smaller in magnitude and too noisy to detect statis-
tical significance. Additional regression analyses, in-
cluding a quintile-exposure regression of AHEI on
weight change and changing length of follow up to
through the end of DPP (an average of 3.2 years of
follow-up) to include weight measurements collected
at each visit through the end of DPP, revealed the
weight change results were linear across the distribu-
tion of AHEI scores and robust to weight changes
over longer time horizons (Supplemental Tables 3
and 4).
Change in AHEI from baseline to 1 year did not
statistically significantly predict incident diabetes
over approximately 3 years of follow-up, in models
without weight change (HR [95% CI] per 10-point
increase, 0.92 [0.82–1.03]) or with weight change
(0.98 [0.87–1.10]) (Table 3). Separate models by
treatment groups were not qualitatively different;
HRs (95% CIs) were 1.01 (0.79–1.30) in ILS, 0.96
(0.78–1.19) in metformin, and 0.98 (0.83–1.16) in
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placebo with adjustment for weight change over the
same year period (p-interaction = 0.959).
We plotted the adjusted HRs in Supplemental Fig. 1 to
visually assess the impact of improvements in AHEI and
weight on time to diabetes, dichotomized by AHEI
change > 10% versus ≤ 10% and weight change of > 5%
versus ≤5% to create four distinct groups. Overall, 40.1%
of participants achieved a ≥ 10% increase in AHEI.
Among those who achieved < 5% weight loss, only 34.5%
achieved a ≥ 10% increase in AHEI whereas among those
who achieved ≥5% weight loss, 50.5% achieved a ≥ 10%
increase in AHEI. Weight change was the driver of dia-
betes onset: the largest effects occur when participants
lost more than 5% weight from baseline where the ad-
justed HR (95% CI) falls from 0.98 (0.80–1.19) to 0.52
(0.39–0.70). Supplemental Fig. 1 presents results for all
treatment groups. We also ran analyses within the ILS
treatment group, who lost the most weight, and found
that the relationship held within this treatment group as
well (Supplemental Fig. 2).
Discussion
We report small improvements in overall diet quality
over the first year of a randomized controlled trial for
the prevention of type 2 diabetes, particularly among
those in the ILS arm. These changes in AHEI were asso-
ciated with statistically significant weight loss across all
treatment arms with the greatest improvements in the
ILS arm (− 1.2 kg per 10-point change in AHEI com-
pared to − 0.5 kg in the placebo arm). However, we did
not find a significant association between changes in
AHEI and incident type 2 diabetes. These results are
Table 1 Baseline Demographics, Participant Characteristics, and AHEI Baseline and Year 1 Scores by treatment arm
All ILS Metformin Placebo p-value
N = 2914 N = 964 N = 977 N = 973
Demographics
Age (years) 50.8 ± 10.6 50.7 ± 11.1 51.3 ± 10.3 50.5 ± 10.3 0.249
Female 1967 (67.5%) 657 (68.2%) 637 (65.2%) 673 (69.2%) 0.151
Race/ethnicity 0.379
% Caucasian 1614 (55.4%) 535 (55.5%) 548 (56.1%) 531 (54.6%)
% African American 564 (19.4%) 172 (17.8%) 200 (20.5%) 192 (19.7%)
% Hispanic 460 (15.8%) 157 (16.3%) 151 (15.5%) 152 (15.6%)
% American Indian 154 (5.3%) 50 (5.2%) 49 (5.0%) 55 (5.7%)
% Asian 122 (4.2%) 50 (5.2%) 29 (3.0%) 43 (4.4%)
Education (years) 14.8 ± 3.1 14.8 ± 3.1 14.9 ± 3.1 14.7 ± 3.2 0.579
Current Smoker 181 (6.2%) 50 (5.2%) 61 (6.2%) 70 (7.2%) 0.187
Family History of Diabetes 2018 (69.3%) 665 (69.1%) 674 (69.0%) 679 (69.9%) 0.899
Hypertensiona 832 (28.6%) 272 (28.2%) 288 (29.5%) 272 (28.0%) 0.728
Characteristics
BMI (kg/m2) 33.9 ± 6.6 33.8 ± 6.7 33.8 ± 6.6 34.2 ± 6.7 0.369
Waist (cm) 105.1 ± 14.4 104.9 ± 14.7 104.9 ± 14.4 105.3 ± 14.2 0.760
Waist-to-Hip 0.92 ± 0.09 0.92 ± 0.09 0.93 ± 0.09 0.92 ± 0.08 0.360
Fasting Glucose (mg/dl) 106.4 ± 8.2 106.3 ± 8.1 106.4 ± 8.4 106.6 ± 8.2 0.772
2-Hour Glucose (mg/dl) 164.6 ± 17.0 164.3 ± 16.8 165.0 ± 17.2 164.4 ± 17.1 0.670
HbA1c (%) 5.9 ± 0.5 5.9 ± 0.5 5.9 ± 0.5 5.9 ± 0.5 0.798
Total daily energy intake (kcal) 1901.4 [1459.8, 2565.4] 1911.1 [1445.7, 2513.3] 1916.0 [1485.2, 2607.3] 1878.2 [1445.1, 2559.0] 0.354
Leisure MET hrs per week 9.9 [3.9, 20.7] 9.9 [3.8, 21.3] 10.1 [4.0, 20.8] 9.5 [4.0, 19.4] 0.713
AHEI Scores
DPP Baseline 44.2 ± 10.4 44.4 ± 10.5 43.8 ± 10.3 44.4 ± 10.5 0.327
DPP Year 1 (Y01) 46.4 ± 10.2 48.6 ± 10.0 45.0 ± 10.0 45.9 ± 10.3 <.001
Difference Baseline to Year 1 2.3 ± 8.8 4.2 ± 9.0 1.2 ± 8.5 1.4 ± 8.4 <.001
Abbreviations: AHEI Alternative Healthy Eating Index, BMI Body Mass Index, DPP Diabetes Prevention Program, HbA1c Hemoglobin A1c, ILS Intensive lifestyle
intervention, MET Metabolic Equivalent
Data are n (%), mean ± SD, or median [Q1, Q3]
aHypertension is defined as meeting any of three criteria: SBP ≥140 mmHg, diastolic blood pressure (DBP) ≥90mmHg, or taking medications that lower
blood pressure
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consistent with those found in Sylvetsky et al. (2017)
who found that high-fiber carbohydrates, and lower total
and saturated fat intake predicted weight loss when ad-
justed for changes in calorie intake, yet these categories
did not predict reductions in diabetes incidence [26].
Our estimates of whole grains, an AHEI subscore cat-
egory, and fats, which are represented by three AHEI
subscores, are closely associated with, but do not com-
prise all of the change in AHEI score that led to weight
loss in this study. Further adjustment for baseline and
change in dietary fiber, carbohydrate, total fat and
saturated fat intake did not negate the relationship be-
tween change in AHEI score and weight loss, as evi-
denced in Table 2.
Though the overall suggestion of eating less fat and
fewer calories often results in improvements in food
choices and a more balanced eating pattern, the ILS
intervention sessions addressed diet quality/food
choices/healthy eating habits directly in only one session,
independent of weight loss goals, and modest changes in
eating patterns were thus observed [19, 27]. The ongoing
intervention for this group involved individual strategies
Fig. 1 Radar plots of AHEI subscores by treatment group and visit. Note: Each subscore adds 0–10 points to the overall score, resulting in a range
of 0–110. Higher scores are associated with greater dietary quality
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further emphasized healthy eating behaviors to achieve
weight loss goals. Diet changes were observed in the life-
style intervention arm [27, 28], which included signifi-
cantly higher fruit intake and lower red meat, dairy, and
sweets intake. These changes were consistent not only
with a lower-fat diet, but also an overall healthier diet
reflective of the Food Guide Pyramid. Our results
suggest that diet quality helps achieve weight loss,
even after adjustment for caloric intake and physical
activity, and that practitioners should also emphasize
Table 2 Effect of change in AHEI (per 10-point increase) on weight change (kg) from baseline to year 1 among participants of the
Diabetes Prevention Program (n = 2914)
N Beta Coefficient Standard Error p-value
Model 1: All participantsa,b 2914 −0.991 0.133 <.0001
Model 2: All participantsa,b 2914 −0.890 0.133 <.0001
Model 3: All participants a,b 2914 −0.512 0.155 0.001
Stratified Models (Model 2)
Treatment group (p-interaction = 0.083)
Lifestyle b 964 −1.232 0.278 <.0001
Metforminb 977 −0.896 0.194 <.0001
Placebob 973 −0.547 0.201 0.007
Racial/ethnic group (p-interaction = 0.020)
Caucasiana 1614 −1.128 0.191 <.0001
African Americana 564 −0.363 0.293 0.216
Hispanica 460 −0.852 0.287 0.003
American Indiana 154 −0.901 0.631 0.155
Asiana 122 + 0.494 0.461 0.286
Model 1: Linear regression models adjusted for baseline values of AHEI, age, sex, BMI, MET hours per week, total energy intake as well as change from baseline to
year one of MET hours per week and total energy intake
Model 2: Linear regression models adjusted for Model 1 covariates as well as baseline values of education, smoking status, family history of diabetes, alcohol use
Model 3: Also adjusted for baseline values of dietary fiber, carbohydrate, total fat and saturated fat at baseline and change to year 1 of each
aAlso adjusted for treatment group
bAlso adjusted for race/ethnicity
Table 3 Effect of AHEI change (per 10-point increase) from baseline to year 1 on time to diabetes over 3.2 years of follow-up in DPP










All participants a,b 2914 0.903 (0.811, 1.006) 0.919 (0.822, 1.026) 0.980 (0.874, 1.098)
Stratified Models
Treatment group p-interaction = 0.9785 p-interaction = 0.9591 p-interaction = 0.9726
Lifestyle b 964 0.884 (0.704, 1.109) 0.856 (0.677, 1.082) 1.013 (0.789, 1.301)
Metforminb 977 0.869 (0.715, 1.058) 0.915 (0.745, 1.123) 0.963 (0.783, 1.185)
Placebob 973 0.933 (0.796, 1.093) 0.957 (0.810, 1.130) 0.981 (0.829, 1.162)
Racial/ethnic group p-interaction = 0.1269 p-interaction = 0.0636 p-interaction = 0.1391
Caucasiana 1614 0.840 (0.727, 0.970) 0.834 (0.716, 0.972) 0.899 (0.767, 1.055)
African Americana 564 1.246 (0.967, 1.607) 1.238 (0.948, 1.615) 1.275 (0.981, 1.657)
Hispanica 460 0.881 (0.682, 1.138) 0.951 (0.727, 1.244) 1.043 (0.788, 1.382)
American Indiana 154 1.161 (0.636, 2.119) 0.603 (0.302, 1.207) 0.662 (0.333, 1.317)
Asiana 122 0.622 (0.336, 1.148) 1.376 (0.656, 2.886) 1.422 (0.666, 3.034)
Model 1: Cox proportional hazard models adjusted for baseline values of AHEI, age, sex, BMI, MET hours, and total energy intake
Model 2: Also adjusted for baseline values of education, smoking status, family history of diabetes, alcohol use, fasting and 2 h glucose as well as change from
baseline to year one of MET hours per week and total energy intake
Model 3: Also adjusted for baseline weight and weight change from baseline to year 1
aAlso adjusted for treatment group
bAlso adjusted for race/ethnicity
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components of an overall healthful diet to maximize
weight loss. This is consistent with the 2015–2020
Dietary Guidelines for Americans, which emphasize
overall dietary patterns rather than specific macro- or
micronutrients [29].
We observed an increase in AHEI score of approxi-
mately 9.5% relative to baseline over 1 year of interven-
tion among ILS participants compared to 2.7% among
metformin and 3.2% among placebo participants. Con-
tent analysis showed that these improvements were
largely driven by participants consuming less sodium
and trans fat, and fewer sugar-sweetened beverages. This
may have been due to the sessions on dietary fat, calorie
balance, and healthy eating out. The results among the
placebo group (average increase of 1.4 points over 1
year) are larger than increases observed in the U.S. gen-
eral population using the 1999–2000 NHANES data.
The AHEI for Americans increased by 0.69 points per
year on average with reductions in consumption of trans
fats intake accounting for more than half of that im-
provement [30].
AHEI had impacts on the weight of Caucasian (− 1.1
kg per 10-point increase in AHEI) and Hispanic (− 0.9
kg per 10-point increase in AHEI) participants. We did
not find a statistically significant association for any
other racial/ethnic groups. This is consistent with the
fact that Caucasian and Hispanic participants had the
greatest increase in AHEI from baseline to 1 year: mean
increase of 2.3 and 3.0, respectively, compared to mean
increases ranging from 1.5 to 1.9 among American In-
dian, African American, and Asian participants. These
findings agree with previous work on the dietary pat-
terns of the DPP by race, which found significant reduc-
tions in dietary fat for Hispanics [27]. A previous
analysis of three prospective cohorts (NHS, NHS II, and
the Health Professionals Follow-up Study) found that
each SD increase in AHEI score was associated with a −
0.47 kg decrease in weight [31], which is very similar to
the − 0.5 kg decrease in weight for each SD increase in
AHEI score among DPP placebo participants in our
study. In a more diverse prospective cohort of Ameri-
cans (Multi-ethnic Study of Atherosclerosis), adherence
to better dietary quality was associated with a statistically
significant 0.54-unit decrease in follow-up BMI among
Caucasian participants and a 0.43-unit decrease in
follow-up BMI among Chinese participants, with similar
reductions among Hispanic participants (0.57-unit de-
crease, p = 0.15), though they were not statistically sig-
nificant, and there was no association among African
American participants (0.08-unit decrease, p = 0.44) [32].
These findings are largely consistent with our findings of
the strongest effects of AHEI on weight loss among
Caucasians. However, these results were found using the
Health Eating Index (HEI), which is measure of
adherence to dietary guidelines not chronic disease risk.
The correlation between the indices is between 0.54–
0.65 [17].
We did not find a statistically significant effect of diet
quality as assessed by AHEI on diabetes incidence, either
independent or mediated through weight loss. Even
among participants who had greater than a 10% increase
in AHEI from baseline to year 1, if sufficient weight loss
was not also achieved (e.g., at least 5%), there was no sig-
nificant reduction in diabetes incidence. This finding is
not consistent with one previous study that analyzed
three prospective cohorts (NHS, NHS II, and the Health
Professionals Follow-up Study) and found that a greater
than 10% increase in AHEI reduced diabetes incidence
by 16% [2]. Our data are substantially different than
NHS, given that they are the result of randomized con-
trolled trial and represent more diverse race/ethnic
groups than the NHS. They also observed that just 32%
of the association between AHEI and diabetes could be
attributed to changes in body weight [2]. One explan-
ation may be that the effects of AHEI on diabetes inci-
dence may only hold for Caucasians. Our results, though
still not significant, were much stronger for Caucasians.
The findings could imply that AHEI may need further
validation as a measure of diet quality in non-
Caucasians.
In addition, we observed that the increases in AHEI
were largely driven by participants consuming less so-
dium, fewer trans fats, and fewer sugar-sweetened bever-
ages. While meta-analyses support a strong, consistent
association between sugar-sweetened beverage intake
and obesity and type 2 diabetes [8], sodium and trans fat
are more strongly associated with hypertension, heart
disease and stroke [33, 34]. The consistent signal for an
association between AHEI and weight loss in our study
is promising, but more research is needed to understand
impacts on subsequent type 2 diabetes, particularly the
relationship between race/ethnicity, diet quality, and dia-
betes incidence.
Several scores have been proposed to quantify diet
quality including the AHEI, the HEI, the DASH diet
score, and Mediterranean-style diet scores. Both DASH
diet scores and Mediterranean-style diets have been as-
sociated with reduced risk of type 2 diabetes in prospect-
ive studies [35–38]. However, the AHEI and ILS
curriculum were developed at different times: AHEI was
first developed in 2010 whereas the ILS curriculum was
developed in 1995. The ILS curriculum focused on
weight loss through a lower-fat diet to reduce overall en-
ergy intake [19]. The ILS curriculum also included a
discussion of the importance of eating more grains, veg-
etables, and fruit, but did not include behavioral goals
related to the intake of these food groups. The AHEI
scores allot up to 30 points for eating healthier types of
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fat, but the DPP curriculum emphasized total fat
reductions and did not emphasize the delineate between
healthier fats initially including intake of sources of
omega-3 fatty acids or PUFA which would have been
consistent with maximizing AHEI scores. Data limita-
tions required us to substitute servings of high fiber
breads and grains for servings of whole grains, How-
ever, our whole grain servings were consistent with
the national levels of whole grain servings found in
Wang et al. (2014), which mitigates this concern [30].
Strengths of our study included the prospective design,
longitudinal assessment of dietary intake, use of a vali-
dated FFQ and estimation of total caloric intake, the di-
verse sample population with high retention rates, and
the gold standard definition of incident type 2 diabetes
rather than relying on self-report as has been done in
previous studies [2]. To the best of our knowledge, this
is the first of the seminal diabetes prevention program
studies to evaluate changes in using a comprehensive
diet quality measure such as AHEI.
Our study, however, is not without limitations. First,
our study is based upon the DDP population. To the
extent that the DDP population does not reflect the
demographic characteristics of the United States, this
constrains the generalizability of our findings. Second,
due to incomplete FFQ data, we substituted daily
servings of high-fiber grains and breads for daily
grams of whole grains. Our AHEI scores for these
categories were in line with population averages cal-
culated by Wang et al. (2014). (27) Finally, we note
that the DDP lifestyle coaching did not specifically
address eating diets associated with a higher AHEI
score. Although, counseling was offered promoting
the consumption of fewer calories and a lower fat
diet.
Conclusions
Many lifestyle interventions for the prevention of type 2
diabetes, including the DPP, emphasize very specific nu-
tritional advice such as reductions in dietary fat intake
to achieve weight loss, which may explain why mainten-
ance of these behaviors over time has proven difficult
[39, 40]. Our results suggest that overall diet quality cap-
tured by 11 components (higher consumption of vegeta-
bles, fruits, high-fiber grains and bread, nuts and
legumes, long-chain omega-3 fatty acids, and PUFAs,
and lower consumption of red/processed meat, sugar-
sweetened beverages and fruit juice, trans fat, and
sodium) from the AHEI score is associated with signifi-
cantly greater weight loss among participants in a ran-
domized controlled trial in the first year. This adds to
the growing literature supporting strong associations be-
tween overall diet quality and weight loss, the latter
generally one of the strongest predictors of type 2 dia-
betes [23, 31, 32]. Practitioners should provide practical
advice centered on these dietary components to promote
healthful diets and weight loss.
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